Glucocorticoids Disrupt Skeletal Angiogenesis Through Transrepression of NF-κB–Mediated Preosteoclast Pdgfb Transcription in Young Mice
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
In the growing skeleton, angiogenesis is intimately coupled with osteogenesis. Chronic, high doses of glucocorticoids (GCs) are associated with decreased bone vasculature and induce osteoporosis and growth failure. The mechanism of GC-suppression of angiogenesis and relationship to osteoporosis and growth retardation remains largely unknown. Type H vessels, which are regulated by preosteoclast (POC) platelet-derived growth factor–BB (PDGF-BB), are specifically coupled with bone formation and development. We determined the effect of GCs on POC synthesis of PDGF-BB in relation to type H vessel formation, bone mass, and bone growth in the distal femur of 2-week-old young mice receiving prednisolone or vehicle for 2, 4, or 6 weeks. After 2 weeks of prednisolone, the number of POCs were unchanged while POC synthesis of PDGF-BB was reduced. Longer treatment with prednisolone reduced POCs numbers and PDGF-BB. These changes were associated with a reduction in type H vessels, bone formation rate, bone mass, and bone length at each time point. In vitro, excessive concentrations of prednisolone (10−6M) resulted in decreased PDGF-BB concentration and POC numbers. Conditioned medium from POC cultures treated with control concentration of prednisolone (10−7M) or recombinant PDGF-BB stimulated endothelial tube formation, whereas conditioned medium from control concentration of prednisolone-treated POC cultures neutralized by PDGF-BB antibody or excessive prednisolone inhibited endothelial tube formation. Administration of excessive prednisolone attenuated the P65 subunit of nuclear factor kappa B (NF-κB) binding to the Pdgfb promoter, resulting in lower Pdgfb transcription. Co-treatment with excessive prednisolone and the glucocorticoid receptor (GR) antagonist (RU486), GR siRNA, or TNFα rescued NF-κB binding to the Pdgfb promoter and endothelial tube formation. These results indicate that PDGF-BB synthesis in POCs is suppressed by GCs through transrepression of GR/NF-κB, thus inhibiting type H vessel formation and associated osteoporosis and growth failure. © 2020 American Society for Bone and Mineral Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
Kusumbe, A. P., Ramasamy, S. K., & Adams, R. H. (2014) · Nature · doi:10.1038/nature13145 · Cited by 2,155 · cited 2×
“The growing skeleton is continually modeled and remodeled during which angiogenesis, specifically type H vessels, plays a critical role in osteogenesis and bone growth.((12,13)) At the border between the growth plate and primary spongiosa, type H blood vessels invade into the growth plate and provide nutrition as well…”
BackgroundWeinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 1×
“Therefore, the effect on bone formation may be due to the known direct effects of GCs inducing apoptosis and inhibiting differentiation of osteoblast lineage cells.((37,47))”
BackgroundPDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis
Xie, H., Cui, Z., Wang, L., Xia, Z., Hu, Y., Xian, L., Li, C., Xie, L., Crane, J., Wan, M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3668 · Cited by 951 · cited 16×
“We have previously reported that POCs are a major source of paracrine PDGF-BB to recruit endothelial tube cells for the formation of type H blood vessels during bone modeling and remodeling.((14)) Our previous study showed a decreased number of PDGF-BB Trap cells after 4 weeks of GC.”
BackgroundMethodResultInfluentialSelf-citationScheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819 · cited 3×
“(28) The Pdgfb promoter region contains a NF-κB binding domain(17,18) and GR is known to regulate NF-κB.”
MethodGlucocorticoid-Induced Osteoporosis
Buckley, L., & Humphrey, M. B. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1800214 · Cited by 438
Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density
Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2006) · Endocrinology · doi:10.1210/en.2006-0459 · Cited by 394
Glucocorticoids suppress bone formation via the osteoclast.
Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384 · cited 3×
“Because the GR is expressed in almost every bone cell,((38,47,55)) we suspect that GC may suppress Pdgfb transcription by a similar mechanism in other cells types than POCs.”
BackgroundResultTreatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181 · cited 1×
“Physiologic cortisol in humans, including children is 5 to 7 mg/m(2)/ day.((34,35)) During times of illness, cortisol levels increase 10-fold to 20-fold (50–100 mg/m(2)/day).”
BackgroundGlucocorticoid dose determines osteocyte cell fate
Jia, J., Yao, W., Guan, M., Dai, W., Shahnazari, M., Kar, R., Bonewald, L., Jiang, J. X., & Lane, N. E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182519 · Cited by 157
Ishida, Y., & Heersche, J. N. M. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.12.1822 · Cited by 155
Glucocorticoid-regulated gene expression during cutaneous wound repair
BEER, H.-D., Fässler, R., & Werner, S. (2000) · Vitamins & Hormones · doi:10.1016/s0083-6729(00)59008-6 · Cited by 113 · cited 1×
“Additionally, we observed decreased PDGF-BB concentration in the bone marrow and serum after 2 weeks of GC exposure, prior to a change in the number of POCs, similar to prior reports of PDGF-BB concentrations in relation to GC in the early phase of wound healing.((52)) We confirmed a significantly decreased PDGF-BB co…”
ResultWithdrawal from glucocorticosteroid therapy: Clinical practice recommendations
Alves, C., Robazzi, T. C. V., & Mendonça, M. (2008) · Jornal de Pediatria · doi:10.2223/jped.1773 · Cited by 72 · cited 1×
“Physiologic cortisol in humans, including children is 5 to 7 mg/m(2)/ day.((34,35)) During times of illness, cortisol levels increase 10-fold to 20-fold (50–100 mg/m(2)/day).”
BackgroundNiu, F., Yao, H., Zhang, W., Sutliff, R. L., & Buch, S. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1139-14.2014 · Cited by 58 · cited 2×
“Through direct protein–protein interactions, GC/GR heterodimers bind to activated NF-κB and prevent it from binding to κB sites, repressing target gene transcription.((53)) We found GCs decreased the binding of NF-κB (P65) to the Pdgfb promoter, which resulted in decreased transcription and PDGF-BB expression in POCs…”
Background
Cited by
The endothelium–bone axis in development, homeostasis and bone and joint disease
Tuckermann, J., & Adams, R. H. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00682-3 · Cited by 258
Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis
Liu, X., Chai, Y., Liu, G., Su, W., Guo, Q., Lv, X., Gao, P., Yu, B., Ferbeyre, G., Cao, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22131-1 · Cited by 116
Self-citationZhen, G., Dan, Y., Wang, R., Dou, C., Guo, Q., Zarr, M., Liu, L. N., Chen, L., Deng, R., Li, Y., et al. (2021) · Bone Research · doi:10.1038/s41413-021-00161-1 · Cited by 47
Self-citation
Metadata
- Authors
- Peng, Y., Lv, S., Li, Y., Zhu, J., Chen, S., Zhen, G., Cao, X., Wu, S., & Crane, J. L.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02-20
- Volume
- 35
- Issue
- 6
- Pages
- 1188-1202
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W3008221579
- Cited by
- 44
- References
- 13
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.